When you're already dealing with reduced appetite from GLP-1s, this might seem counterintuitive
100% achieved 5% Weight loss was dose-dependent: 4mg (-17.1%), 8mg (-22.8%), 12mg (-24.2%) at 48 weeks Results appeared early (visible by week 4) and continued throughout the 48-week trial Beyond weight: significant improvements in blood pressure, lipids, liver fat, and glycemic control Investigational Drug: Retatrutide is not FDA-approved
doi: 10.1002/phy2.112 Summary Keywords dual agonist-receptor, IBI362, diabetes, Mazdutide, obesity, overweight Citation Nalisa DL, Cuboia N, Dyab E, Jackson IL, Felix HJ, Shoki P, Mubiana M, Oyedeji-Amusa M, Azevedo L and Jiang H (2024) Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials
Apart from stringent testing, Montiff creates its products using only USP, pharmaceutical-grade, or the highest-quality active amino acids, vitamins, antioxidants, and botanicals to create its products
